Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF LEASE RELATED EXPENSE FROM THE TRANSITION FROM IFRS TO GAAP (Details)

v3.24.1
SCHEDULE OF LEASE RELATED EXPENSE FROM THE TRANSITION FROM IFRS TO GAAP (Details) - GBP (£)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Research and development expenses £ 7,771,391 £ 7,592,470
Administrative expenses 6,467,932 7,030,972
Interest expense   (6,755,438)
Total Conversion Adjustments   76,105
Net loss £ (5,906,953) £ (1,313,601)
Weighted-average common shares outstanding - basic [1] 6,178,423 687,199
Weighted-average common shares outstanding - diluted [1] 6,178,423 687,199
Basic net loss per share £ (0.96) £ (1.91)
Diluted net loss per share £ (0.96) £ (1.91)
Operating lease right of use assets £ 1,340,769 £ 1,530,274
Total Conversion Adjustments 8,931,664 11,291,977
Non-current operating lease liability 1,495,833 1,796,835
Accumulated deficit (38,837,290) (33,374,796)
Total Conversion Adjustments £ 8,931,664 11,291,977
Previously Reported [Member]    
Research and development expenses   7,447,506
Administrative expenses   7,013,056
Interest expense   (6,994,423)
Net loss   £ (1,389,706)
Weighted-average common shares outstanding - basic   687,199
Weighted-average common shares outstanding - diluted   687,199
Basic net loss per share   £ (2.02)
Diluted net loss per share   £ (2.02)
Operating lease right of use assets   £ 1,188,947
Non-current operating lease liability   1,812,450
Accumulated deficit   (33,731,738)
Revision of Prior Period, Reclassification, Adjustment [Member]    
Research and development expenses   144,964
Administrative expenses   17,916
Interest expense   (238,985)
Total Conversion Adjustments   (76,105)
Net loss   £ (76,105)
Weighted-average common shares outstanding - basic  
Weighted-average common shares outstanding - diluted  
Basic net loss per share   £ 0.08
Diluted net loss per share   £ 0.08
Operating lease right of use assets   £ 341,327
Total Conversion Adjustments   341,327
Non-current operating lease liability   (15,615)
Accumulated deficit   356,942
Total Conversion Adjustments   £ 341,327
[1] On November 18, 2022, the Company completed a reverse stock split of one (1) new share for every fifty (50) existing shares effective November 21, 2022. As a result of the share split, all references in these financial statements and accompanying notes to units of ordinary shares or per share amounts are reflective of the reverse share split for all periods presented. In addition, the exercise prices and the numbers of ordinary shares issuable upon the exercise of any outstanding options to purchase ordinary shares were proportionally adjusted pursuant to the respective anti-dilution terms of the share-based payment plans.